title: Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region.
abstract: The transactivator protein, tat, encoded by the human immunodeficiency virus is a key regulator of viral transcription. Activation by the tat protein requires sequences downstream of the transcription initiation site called the transactivating region (TAR). RNA derived from the TAR is capable of forming a stable stem-loop structure and the maintenance of both the stem structure and the loop sequences located between +19 and +44 is required for complete in vivo activation by tat. Gel retardation assays with RNA from both wild-type and mutant TAR constructs generated in vitro with SP6 polymerase indicated specific binding of HeLa nuclear proteins to the TAR. To characterize this RNA-protein interaction, a method of chemical "imprinting" has been developed using photoactivated uranyl acetate as the nucleolytic agent. This reagent nicks RNA under physiological conditions at all four nucleotides in a reaction that is independent of sequence and secondary structure. Specific interaction of cellular proteins with TAR RNA could be detected by enhanced cleavages or imprints surrounding the loop region. Mutations that either disrupted stem base-pairing or extensively changed the primary sequence resulted in alterations in the cleavage pattern of the TAR RNA. Structural features of the TAR RNA stem-loop essential for tat activation are also required for specific binding of the HeLa cell nuclear protein.
authors.affiliation: Molecular Biology Institute, School of Medicine, University of California, Los Angeles.
authors.forename: R
authors.initials: R
authors.lastname: Gaynor
authors.forename: E
authors.initials: E
authors.lastname: Soultanakis
authors.forename: M
authors.initials: M
authors.lastname: Kuwabara
authors.forename: J
authors.initials: J
authors.lastname: Garcia
authors.forename: D S
authors.initials: DS
authors.lastname: Sigman
mesh_terms: D001483:Base Sequence; D015696:Gene Products, tat; D006678:HIV / Q000235:genetics* / Q000378:metabolism; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000378:metabolism*; D009690:Nucleic Acid Conformation; D009856:Oncogene Proteins, Viral / Q000235:genetics*; D011485:Protein Binding; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics*; D014158:Transcription, Genetic; D054322:tat Gene Products, Human Immunodeficiency Virus
chemical_list: D015696:Gene Products, tat; D009687:Nuclear Proteins; D009856:Oncogene Proteins, Viral; D012367:RNA, Viral; D014157:Transcription Factors; D054322:tat Gene Products, Human Immunodeficiency Virus